| ID: 100310785 | Leukemia, acute lymphocytic, susceptibility to, 1 [Homo sapiens (human)] | | | 613065 |
| ID: 8021 | nucleoporin 214 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (131125586..131234663) | CAIN, CAN, IIAE9 | 114350 |
| ID: 6887 | TAL bHLH transcription factor 2 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (105662457..105663124) | | 186855 |
| ID: 6886 | TAL bHLH transcription factor 1, erythroid differentiation factor [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (47216290..47232335, complement) | SCL, TCL5, bHLHa17, tal-1 | 187040 |
| ID: 4683 | nibrin [Homo sapiens (human)] | Chromosome 8, NC_000008.11 (89933331..89984667, complement) | AT-V1, AT-V2, ATV, NBS, NBS1, P95, hNbs1 | 602667 |
| ID: 2782 | G protein subunit beta 1 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (1785286..1891087, complement) | HG2A, MDS, MRD42 | 139380 |
| ID: 2322 | fms related receptor tyrosine kinase 3 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (28003274..28100576, complement) | CD135, FLK-2, FLK2, STK1 | 136351 |
| ID: 613 | BCR activator of RhoGEF and GTPase [Homo sapiens (human)] | Chromosome 22, NC_000022.11 (23180509..23318037) | ALL1, CML, D22S11, D22S662, PHL, BCR | 151410 |
| ID: 581 | BCL2 associated X, apoptosis regulator [Homo sapiens (human)] | Chromosome 19, NC_000019.10 (48954875..48961798) | BCL2L4 | 600040 |